NCT07457606

Brief Summary

Objectives: To compare the outcomes of partial turbinectomy versus mucosal diathermy in patients with inferior turbinate hypertrophy. Methodology: The ENT Department at Sheikh Zayed Hospital in Lahore carried out this non-randomized controlled study. Total 60 adults between the ages of 18 and 60 who have been diagnosed with inferior turbinate hypertrophy were included. Septal deviation, or other major sinonasal diseases; uncontrolled allergic rhinitis; prior nasal or turbinate surgery were excluded. In group A patients partial inferior turbinectomy (PIT) was done while in group B, submucosal diathermy (SMD) was done. A 10-point Visual Analogue Scale (VAS) was used to measure nose pain on the first postoperative day and at the one-month follow-up. Nasal obstruction scores (Grades 0-3) were assessed both before and after surgery at one and three months. Using Lund and Kennedy's standardized grading method, nasal crusting was assessed. At three-month follow-up visits, tissue healing quality was evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 27, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 26, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 9, 2026

Completed
Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

February 26, 2026

Last Update Submit

March 3, 2026

Conditions

Keywords

turbinectomypartialdiathermy

Outcome Measures

Primary Outcomes (3)

  • Rate of Nasal Obstruction

    one month

  • Incidence of Nasal Pain

    one month

  • Rate of Nasal Crusting

    one month

Study Arms (2)

partial turbinectomy

ACTIVE COMPARATOR
Procedure: partial turbinectomy

mucosal diathermy

EXPERIMENTAL
Procedure: submucosal diathermy

Interventions

After achieving adequate anesthesia and decongestion, the inferior turbinate will be visualized using a nasal speculum or endoscope. The medial one-third of the hypertrophied turbinate, including both the mucosal covering and underlying bony structure, will be carefully removed using turbinectomy scissors. The resection will be limited to the anterior two-thirds of the turbinate, avoiding injury to the posterior end. Bleeding points will be controlled using bipolar cautery or nasal packing as needed

partial turbinectomy

Once the turbinate is exposed, an insulated diathermy needle will be inserted into the submucosal layer at the anterior end of the inferior turbinate. The needle will be advanced along the turbinate's length, staying close to the bone. A low-voltage coagulation current will be applied during withdrawal of the needle, typically in two to three passes to cover the superior, middle, and inferior aspects of the turbinate. This causes shrinkage of the submucosal tissue while keeping the outer mucosa mostly intact. Hemostasis will be ensured before the procedure is completed

mucosal diathermy

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Confirmed diagnosis of inferior turbinate hypertrophy.
  • Persistent nasal obstruction symptoms for over 6 months.
  • Inadequate response to conservative medical treatments like intranasal corticosteroids and antihistamines for at least 3 months

You may not qualify if:

  • Causes of nasal obstruction other than nasal polyps, septal deviation, sinusitis, or other major sinonasal diseases.
  • Uncontrolled allergic rhinitis or undergoing immunotherapy.
  • Previous nasal or turbinate surgery.
  • Systemic diseases affecting nasal mucosa such as Wegener's granulomatosis, sarcoidosis, or cystic fibrosis.
  • Pregnancy or breastfeeding.
  • Bleeding disorders or use of anticoagulant therapy.
  • Inability to adhere to the study protocol or cognitive impairments affecting understanding and compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaikh Zayed Hospital, Lahore

Lahore, Punjab Province, 60000, Pakistan

Location

MeSH Terms

Conditions

Fever

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • mudassar saeed pansota

    Assistant Professor of Urology, Shahida Islam Teaching Hospital, Lodhran, Pakistan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical professor

Study Record Dates

First Submitted

February 26, 2026

First Posted

March 9, 2026

Study Start

September 27, 2025

Primary Completion

November 26, 2025

Study Completion

December 25, 2025

Last Updated

March 9, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations